Aviation startup Merlin Labs valued at $800 million in deal to go public
Last year, the company landed a $105 million contract with the Department of Defense to integrate Merlin Pilot software into the C-130J airlifter manufactured by Lockheed Martin.
Inflection Point chief executive Mike Blitzer will join the Merlin board as a result of the upcoming deal; Inflection Point's recent successes include two other companies launched through similar SPAC deals, USA Rare Earth (current market cap of $1.7 billion) and Intuitive Machines (worth $1.6 billion today).
Jon Chesto can be reached at
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
5 hours ago
- CBS News
Autonomous planes being developed by Boston company aiming to fix pilot shortage
Most people have heard of autonomous cars. But what about autonomous planes? A Boston company is now working to put the pilotless planes in the sky. "The air is still quite dangerous, so if we can get humans out of harm's way, particularly for our [Department of Defense] customers, that's a really important mission for us," Merlin CEO & founder Matt George said. The Boston-based company develops cost-effective takeoff-to-touchdown airplanes. "Merlin is the leading developer of autonomy for very large airplanes like this! The best way to think about what we're building is a pilot, just not a human one, to enable our customers and partners to go fly their airplanes in pretty new and interesting ways including some, eventually, uncrewed stuff in the future," George said. Inside the Merlin Pilots lab on South Street in Boston, folks are busy developing new state-of-the-art technology that takes the skills of a human pilot and translates them into AI software. George said the goal is to help tackle the pilot shortage in America. "The Air Force is our largest customer, they're short about 2,000 pilots a year of seats that they wish they can fill but can't fill. And now we're transitioning in the age where autonomy and AI is going to play a really important part in aviation and in aviation safety and allowing folks to use the sky in some new and novel ways," George said. They have 170 employees working at the frontier of aviation and are proud to be here in Boston. "Historically Boston was the tech hub. So, I'm really proud of the fact that we're starting to bring some of these frontiers, really hard technologies both in biotech, in aerospace and nuclear with Commonwealth Fusion back to Boston," George said. So with all this high tech does not mean you will go to Logan and see any autonomous planes anytime soon. In fact, George said there's no telling when folks will come to the airport and board a plane without a pilot. "I wouldn't put a number on it. I am certainly not betting on showing up to my Delta or American Airlines flight and seeing nobody aboard the flight deck. Human pilots are still a really important part of that future. We're just bringing autonomy in to augment those folks," said George.
Yahoo
7 hours ago
- Yahoo
Lockheed Martin to open large missile assembly building in Courtland early 2026
COURTLAND, Ala. (WHNT) — A major American defense contractor is expanding its operations in North Alabama by bringing another large facility to a small town in Lawrence County. Lockheed Martin told News 19 that a new 88,000 square-foot Missile Assembly Building is currently under construction in Courtland. The new building is expected to open early 2026, the company said. Lockheed Martin said the spacious building will help advance defense systems in Courtland. The building is being built for the Next Generation Interceptor program. Lockheed Martin's website says with the NGI program, the mission is to 'develop, produce and deliver a modern, never-fail weapon against increasing and evolving ballistic missile threats from rogue nations. NGI is a first line of defense, tip-to-tail interceptor within the Missile Defense Agency's Ground-based Midcourse Defense (GMD) system.' The company said Courtland currently supports critical defense programs for the Army, Navy and Missile Defense Agency. Over 400 employees currently work at the Courtland site, and Lockheed said it expects an increase in workforce in 2026 following the opening of the new building. 'We're not just working on defense programs. We're defining what the future of missile defense looks like,' Lockheed Martin said. The company has a long-standing relationship with the town of Courtland. In 2019, the company announced that it would have a Hypersonic Strike Work manufacturing plant with two new buildings. The Aerospace and Defense company broke ground at the site in September 2019 and it was officially opened on October 4, 2021. The milestone of opening this building established northern Alabama as the 'Home of Hypersonic Strike Production,' Lockheed Martin said. In 2023, Lockheed Martin developed a partnership with the town of Courtland and helped convert its part-time fire department into a full-time, 24/7 emergency service with new equipment and staffing. Through a partnership with the State of Alabama, Lockheed Martin said it received a $1.8 million infrastructure grant to improve roads around the 88,000 square-foot facility. 'Lockheed Martin is building advanced defense systems in Courtland, but more importantly, we are investing in the future of the community. From workforce development and infrastructure upgrades to enhanced emergency services, our commitment extends beyond our facility. Real progress happens when industry and community grow together, and we are proud to help build a stronger, more resilient future for Courtland and the surrounding region.' Sarah ReevesVice President, Next Generation Interceptor (NGI) Program Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
8 hours ago
- Yahoo
Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes
LAVAL, QC / / August 15, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company") today announced that Paulson Capital Inc. and certain affiliates and managed funds have increased their ownership of the Company's common shares. The increase reflects the acquisition by Paulson Capital Inc. and certain affiliates and managed funds of the net long position of 34,721,118 common shares previously held by Mr. Carl C. Icahn and his affiliates (collectively, "Icahn Group"). The Company is not a party to any agreement or arrangement with Paulson Capital Inc. or its affiliates or the Icahn Group in connection with these transactions. Based on information provided to the Company, Paulson Capital Inc. and certain affiliates and managed funds beneficially owns approximately 19.13% of the Company's outstanding common shares as of the date hereof. The Company further announced that the Director Appointment and Nomination Agreement, dated as of February 23, 2021, between the Company and Icahn Group, terminated pursuant to its terms when the Icahn Group's net long position in the Company's shares fell below the specified threshold. In connection with the termination, Brett M. Icahn and Steven D. Miller have resigned from the Board of Directors (the "Board"). "I believe there is significant value in Bausch Health and am confident in the Company's efforts to maximize shareholder value. I am excited about the underlying business prospects in both Bausch Health and its subsidiary, Bausch + Lomb Corporation," John A. Paulson, Chairperson of the Bausch Health Board, said. "I also want to thank Brett and Steven for their dedication and valuable contributions to the Company." About Bausch Health Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit and connect with us on LinkedIn. Forward-looking Statements This news release may contain forward-looking statements within the meaning of applicable securities laws, including the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of the words "will," "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "subject to" and variations or similar expressions. These statements are neither historical facts nor assurances of future performance, are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health's overall business, including those more fully described in Bausch Health's most recent annual and quarterly reports and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to update any of these forward-looking statements to reflect events, information or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. Investor Contact: Media Contact: Garen Sarafian Katie Savastano ir@ (877) 281-6642 (toll free) (908) 569-3692 SOURCE: Bausch Health Companies Inc. View the original press release on ACCESS Newswire Sign in to access your portfolio
